Aethlon Medical Inc plans to issue shares of its common stock in a public offering to raise up to $13.28m.
The American company plans to use the funds to progress the development of its products as well as towards working capital and general corporate purposes.
US-based radiation oncology company Accuray Inc has announced the private placement of senior unsecured notes to raise $32m.
Due 15 July 2022, the notes carry an interest rate of 3.75% a year.
Accuray plans to use the funds to repurchase $28m of existing notes.
See Also:
Chinese molecular diagnostics company Amoy Diagnostics Co Ltd has announced the completion of an initial public offering (IPO) of 20 million shares priced at CNY13.86 ($2.06) each to raise CNY277m ($41.21m).
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataAmoy plans to use the funds from the IPO towards new product investment, marketing, and R&D expansion.
Invitae Corp plans to issue eight million preferred shares, priced at $8.5 a share, in a private placement to raise $73.5m.
The US-based genetic information company plans to use the proceeds to expand its business.